4,4′-DMAR in-vivo acute cardiotoxicity: differences between (±)cis-4,4′-DMAR and its coadministration with the (±)trans-4,4′-DMAR isomer - Takeaways - MDSpire

4,4′-DMAR in-vivo acute cardiotoxicity: differences between (±)cis-4,4′-DMAR and its coadministration with the (±)trans-4,4′-DMAR isomer

  • By

  • Giorgia Corli

  • Elisa Roda

  • Beatrice Marchetti

  • Micaela Tirri

  • Sabrine Bilel

  • Marta Bassi

  • Beatrice Benedetti

  • Elena Cavarretta

  • Giacomo Frati

  • Fabrizio De Luca

  • Carlo Alessandro Locatelli

  • Fabio De-Giorgio

  • Matteo Marti

  • June 16, 2026

  • 0 min

Share

  • 1

    4,4′-DMAR is a synthetic stimulant with two stereoisomers, (±)cis-4,4′-DMAR and (±)trans-4,4′-DMAR, exhibiting distinct pharmacological effects.

  • 2

    Administration of (±)cis-4,4′-DMAR at 10 mg/kg and its coadministration with (±)trans-4,4′-DMAR resulted in severe cardiorespiratory toxicity in mice.

  • 3

    Tachycardia, narrow-QRS arrhythmias, and respiratory impairments were observed following treatment, indicating significant cardiovascular risks.

  • 4

    Immunohistochemical analysis revealed inflammation and oxidative stress markers in heart tissues, suggesting structural damage from 4,4′-DMAR.

  • 5

    The study highlights the dangers of 4,4′-DMAR intoxication, emphasizing the importance of dosage and stereoisomer interactions in toxicity.

Original Source(s)

4,4′-DMAR in-vivo acute cardiotoxicity: differences between (±)cis-4,4′-DMAR and its coadministration with the (±)trans-4,4′-DMAR isomer

  • by Giorgia Corli, Elisa Roda, Beatrice Marchetti, Micaela Tirri, Sabrine Bilel, Marta Bassi, Beatrice Benedetti, Elena Cavarretta, Giacomo Frati, Fabrizio De Luca, Carlo Alessandro Locatelli, Fabio De-Giorgio, Matteo Marti

  • June 16, 2026

Related Content

Combined Influence of Waist Circumference Patterns and Aging on Heart Disease Risk

How FIU and Baptist Health are Using AI and Sound to Detect Heart Disease Earlier

Researchers at Florida International University (FIU), working in collaboration with Baptist Health South Florida, are combining a digital stethoscope with artificial intelligence (AI) and advanced sound analysis to better detect subtle signs of heart disease long before symptoms appear.

  • March 31, 2026

  • 5 min
Reference Standards for Blood Pressure Response During Peak Exercise in Pediatric Patients with Structurally Normal Hearts